Clinical manifestation, prevalence and prognosis of sarcoid arthropathy a nationwide study: The Icelandic Sarcoidosis Study

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 24, Issue 2, 2007, Pages 113-120

  Petursdottir, Dyrleif ^a   Haraldsdottir, Sigridur O ^a   Gislason, Thorarinn ^a   Gudbjornsson, Bjorn ^a  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

Author keywords

Arthritis; Arthropathy; Clinical manifestation; Epidemiology; Nationwide study; Prognosis; Sarcoidosis

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; NONSTEROID ANTIINFLAMMATORY AGENT;

ACUPUNCTURE; ADULT; AGED; ARTHRITIS; ARTHROPATHY; ARTICLE; CHIROPRACTIC; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GROUPS BY AGE; HUMAN; ICELAND; INTERVIEW; MALE; OCCUPATIONAL THERAPY; PHYSICAL EXAMINATION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; QUESTIONNAIRE; RADIODIAGNOSIS; RISK FACTOR; SARCOIDOSIS;

ADULT; AGED; ARTHRITIS; COHORT STUDIES; FEMALE; HUMANS; ICELAND; INCIDENCE; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; QUESTIONNAIRES; REGISTRIES; SARCOIDOSIS;

EID: 41149091660     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Baughman RP, Lower EE, du Bois RM: Sarcoidosis. Lancet 2003; 361: 1111-8.
2. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999; 160: 736-55.
3. Gordis L: Sarcoidosis: Epidemiology of Chronic Lung Diseases in Children. Baltimore, 1973.
4. Iwai K, Sekiguti M, Hosoda Y, DeRemee RA, Tazelaar HD, Sharma OP, Maheshwari A, Noguchi TI: Racial difference in cardiac sarcoidosis incidence observed at autopsy. Sarcoidosis 7994; 11: 26-31.
5. Milman N, Selroos O: Pulmonary sarcoidosis in the Nordic countries 1950-1982. II. Course and prognosis. Sarcoidosis 1990; 7: 113-8.
6. Byg KE, Milman N, Hansen S: Sarcoidosis in Denmark 1980-1994: A registry-based incidence study comprising 5536 patients. Sarcoidosis Vasc Diffuse Lung Dis 2003; 20: 46-52.
7. James GD: Sarcoidosis and Other Granulomatous Disorders. New York, Marcel Dekker, 1994.
8. Mana J, Badrinas F, Morera J, Fite E, Manresa F, Fernandez-Nogues F: Sarcoidosis in Spain. Sarcoidosis 1992; 9: 118-22.
9. Siltzbach LE, James DG, Neville E, Turiaf J, Battesti JP, Sharma OP, Hosoda Y, Mikami R, Odaka M: Course and prognosis of sarcoidosis around the world. Am J Med 1974; 57: 847-52.
10. Rybicki BA, Major M, Popovich J Jr, Maliarik MJ, Iannuzzi MC: Racial differences in sarcoidosis incidence: A 5-year study in a health maintenance organization. Am J Epidemiol 1997; 145:234-41.
11. Kaplan H: Sarcoid Arthritis. A Review. Arch Intern Med 1963; 112: 924-35.
12. Kelley WN: Textbook of Rheumatology, ed 5th, Philadelphia, W. B. Saunders, 1997.
13. Soderlin MK, Borjesson O, Kautiainen H, Skogh T, Leirisalo-Repo M: Annual incidence of inflammatory joint diseases in a population based study in southern Sweden. Ann Rheum Dis 2002;61:911-5.
14. Glennas A, Kvien TK, Melby K, Refvem OK, Andrup O, Karstensen B, Thoen JE: Acute sarcoid arthritis: Occurrence, seasonal onset, clinical features and outcome. Br J Rheumatol 1995; 34: 45-50.
15. Gran JT, Böhmer E: Acute sarcoid arthritis: A favourable outcome? A retrospective survey of 49 patients with review of the literature. Scand J Rheumatol 1996; 25: 70-3.
16. Torralba KD, Quismorio FP, Jr.: Sarcoid arthritis: a review of clinical features, pathology and therapy. Sarcoidosis Vasc Diffuse Lung Dis 2003; 20: 95-103.
17. Grigor RR, Hughes GR: Chronic sarcoid arthritis. Br Med J 1976; 2: 1044.
18. Scott DG, Porto LO, Lovell CR, Thomas GO: Chronic sarcoid synovitis in the Caucasian: An arthroscopic and histological study. Ann Rheum Dis 1981, 40: 121-3.
19. Visser H, Vos K, Zanelli E, Verduyn W, Schreuder GM, Speyer I, Breedveld FC, Hazes JM: Sarcoid arthritis: clinical characteristics, diagnostic aspects, and risk factors. Ann Rheum Dis 2002; 61: 499-504.
20. Pennee Y, Youinou P, Le Goff P, Boles JM, Le Menn G: Comparison of the manifestations of acute sarcoid arthritis with and without erythema nodosum. Immunopathogenic significance. Scand J Rheumatol 1982; 11: 13-6.
21. Haraldsdottir SO, Jorundsdottir KB, Yngvason F, Bjornsson J, Gislason.Sarcoidosis in Iceland 1981-2003. Læknabla∂i∂ 2007; 93: 103-7.
22. Buchbinder R, Bombardier C, Yeung M, Tugwell P. Which outcome measures should be used in rheumatoid arthritis clinical trials? Clinical and quality-of-life measures' responsiveness to treatment in a randomized controlled trial. Arthritis Rheum 1995; 38: 1568-80.
23. Online Database, http://www.statice.is [homepage on the internet]. Population by sex and age 1840-2003.
24. Revsbech P: Is sarcoidosis related to exposure to pets or the housing conditions? A case-referent study. Sarcoidosis 1992; 9: 101-3.
25. Newman LS, Rose CS, Bresnitz EA, et al. A case control etiologic study of sarcoidosis: Environmental and occupational risk factors. Am J Respir Crit Care Med 2004; 170: 1324-30.
26. The Public Health Institute of Iceland; http://www-lydheilsustod.is
27. McGrath J, McDonald JW, Macdonald J. Transdermal nicotine for induction of remission in ulcerative colitis. Cochrane Database Syst Rev 2004; 18: CD004722.
28. Patel GK, Rhodes JR, Evans B, Holt PJ Successful treatment of pyoderma gangrenosum with topical 0.5% nicotine cream. J Dermatolog Treat 2004; 15: 122-5
29. Newman LS, Rose CS, Maier LA. Sarcoidosis (review). N Engl J Med 1997; 36: 1224-34.
30. Glennas A, Kvien TK, Melby K, et al. Acute sarcoid arthritis: occurrence, seasonal onset, clinical features and outcome. Br J Rheumatol 1995; 34: 45-50.
31. Johns CJ, Michele TM: The clinical management of sarcoidosis: A 50-year experience at the Johns Hopkins Hospital. Medicine (Baltimore) 1999; 78: 65-111.
32. Rybicki BA, Iannuzzi MC, Frederick MM, et al: Familial Aggregation of Sarcoidosis: A Case-Control Etiologic Studey of Sarcoidosi (ACCESS). Am J Respir Crit Care Med 2001; 164: 2085-91.